Mangalam Global (MGEL)
Fast GrowerScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹14.43 |
| Market Cap | ₹475.55 Cr |
| P/E Ratio | 10.09 |
| ROCE | 16.75% |
| ROE | 19.03% |
| Dividend Yield | 0.07% |
| Profit Growth | 30% |
| Debt/Equity | 0.87 |
| Sales Growth | 10.9% |
| Free Cash Flow | ₹88,036.25 Cr |
| Promoter Holding | 71.46% |
| 52-Week Range | ₹9.53 — ₹18.4 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹7.55 |
Strengths
- Sales grew 50.58% and profit grew 22.98%, showing strong momentum
- ROE of 19.03% and ROCE of 16.75% indicate capital-efficient operations
- Piotroski F-Score of 7/9 suggests solid financial health
- Promoter holding of 71.46% aligns management with minority shareholders
- P/E of 13.12 and PEG of 0.36 make valuation reasonable if growth sustains
Concerns
- Latest quarter net margin is razor-thin: ₹9 Cr profit on ₹756 Cr sales (~1.2%)
- Profit growth of 22.98% lags sales growth of 50.58%, implying margin compression
- Debt/equity of 0.87 is notable for a low-margin commodity business
- Reported FCF of ₹88,036 Cr is anomalous versus market cap of ₹364 Cr and needs reconciliation
AI Analysis
At ₹13.96, Mangalam Global’s ₹364 crore market cap looks interesting, but I need to understand what I’m buying. The business grows: sales up 50.58%, profits up 22.98%, and at 19.03% ROE it earns attractive returns on equity without extreme leverage—debt/equity is 0.87, manageable though not debt-free. The Piotroski F-Score of 7/9 also tells me the balance sheet isn’t deteriorating. What worries me is the quality of these earnings. Latest quarter sales of ₹756 crore produced only ₹9 crore net profit—a net margin of barely 1.2%. That is a razor-thin, high-turnover commodity business, likely with limited pricing power. The 50% sales growth with only 23% profit growth confirms that margins are being squeezed; not all sales are equal. The moat? I don't see one yet. Agricultural products are commoditized, and any temporary export or crop cycle can distort both revenue and earnings. The reported free cash flow of ₹88,036 crore is absurd versus a ₹364 crore market cap—I would treat that number as a red flag in need of reconciliation, not a gift. Valuation at 13.12 times earnings and 2.5 times book is not unreasonable for a 23% profit grower, and the PEG of 0.36 suggests the market is pricing no growth. But the ₹9.53 to ₹18.40 range reminds me this is a volatile small cap. With promoters holding 71.46%, I like alignment, but the 0.09% dividend yield means patient investors are paid nothing to wait. I'd want to see several more quarters of margin stability and real cash conversion before investing.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer